Calendar Predictive Oncology Inc.

Equities

POAI

US74039M3097

Market Closed - Nasdaq 04:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
1.66 USD +23.88% Intraday chart for Predictive Oncology Inc. +44.34% -49.54%

Chart calendar Predictive Oncology Inc.

3dc71bc18ed273a453b3021126ebaaf.HgRCOAyt3NvS_i_7fJ0Ya654Hid84qglaAPMs4AkOHU.KG5ybGnnhKyEpGmpHt90A8AAaUwtoYUIDluUgckXUwZaT29WRMetubesdg~899194673a6a64e208675aa96dc6775f

Upcoming events on Predictive Oncology Inc.

2024-05-13 Q1 2024 Earnings Release (Projected)
2024-06-03 10:00 am American Society of Clinical Oncology Annual Meeting - Abstract No: 5555
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-13 Q3 2024 Earnings Release (Projected)
2025-04-07 Q4 2024 Earnings Release (Projected)

Past events on Predictive Oncology Inc.

2024-04-03 09:40 am MedInvest Biotech & Pharma Investor Conference
2024-04-01 08:30 am Q4 2023 Earnings Call
2024-03-28 05:28 pm Q4 2023 Earnings Release
2024-03-07 02:00 pm H.C. Wainwright Artificial Intelligence Based Drug Discovery & Development Virtual Conference - Fire
2024-03-01 02:30 pm NeauxCancer Oncology Conference
2024-02-27 09:00 am BIO CEO & Investor Conference
2024-01-09 Biotech Showcase
2023-11-14 08:30 am Q3 2023 Earnings Call
2023-11-14 07:00 am Q3 2023 Earnings Release
2023-08-10 05:30 pm Q2 2023 Earnings Call
2023-08-10 05:15 pm Q2 2023 Earnings Release
2023-06-05 02:45 pm BIO International Convention
2023-05-15 05:30 pm Q1 2023 Earnings Call
2023-05-15 05:15 pm Q1 2023 Earnings Release
2023-04-19 04:00 pm Extraordinary Shareholders Meeting - Second Call
2023-04-17 04:00 pm Extraordinary Shareholders Meeting - First Call
2023-03-22 05:15 pm Q4 2022 Earnings Release
2023-03-22 12:00 pm Q4 2022 Earnings Call
2023-02-05 BIO CEO & Investor Conference
2022-11-10 05:15 pm Q3 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021
Net sales
Million USD
Released
Forecast
Spread
1,41


1,25
1,31
-4.26%
1,42
3,42
-58.48%
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-12,5
-12,5
-0.2%
-13,5
-12,2
-10.82%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-25,9
-17,6
-47.46%
-20,3
-13,6
-49.95%
Net income
Million USD
Released
Forecast
Spread
0,00


-26,4
-17,6
-50.61%
-19,7
-13,6
-45.07%
EPS
USD
Released
Forecast
Spread
-137


-44,2
-29,6
-49.32%
-7,20
-4,90
-46.94%
Announcement Date01/04/2015/03/2131/03/22

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q3
Net sales
Million USD
Released
Forecast
Spread
0,48
2,50
-80.94%
0,31
1,00
-68.54%



EBIT
Million USD
Released
Forecast
Spread
-4,42
-3,10
-42.45%
-3,41
-2,48
-37.66%



Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,42
-1,65
-410.19%
-3,37
-2,48
-35.92%



Net income
Million USD
Released
Forecast
Spread
-7,76
-1,65
-370.09%
-3,37
-2,48
-35.92%
-4,06


EPS
USD
Released
Forecast
Spread
-2,60
-0,50
-420%
-1,00
-0,80
-25%
-1,00


Announcement Date31/03/2212/05/2210/11/22

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. POAI Stock
  4. Calendar Predictive Oncology Inc.